IP Library Granted Patent US 7,714,088
Granted Patent B2
US 7,714,088 · App. 12/410,438 · Granted May 11, 2010

Poly(ethylene glycol) derivatives with proximal reactive groups

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,714,088
App. No.
12/410,438
Granted
May 11, 2010
Kind
B2
Abstract

An activated, substantially water-soluble poly(ethylene glycol) is provided having of a linear or branched poly(ethylene glycol) backbone and at least one terminus linked to the backbone through a hydrolytically stable linkage, wherein the terminus is branched and has proximal reactive groups. The free reactive groups are capable of reacting with active moieties in a biologically active agent such as a protein or peptide thus forming conjugates between the activated (polyethylene glycol) and the biologically active agent.

Claims (39)

1. A method comprising covalently linking a water soluble polymer to a biologically active agent, wherein the water soluble polymer comprises the following structure:

wherein:

POLY is a water-soluble, substantially non-immunogenic polymer;

Y is a hydrolytically stable linkage;

W is a first tethering group;

W′ is a second tethering group;

Z is a first reactive moiety; and

Z′ is a second reactive moiety.

2. The method of claim 1 , wherein the first reactive moiety, Z, and the second reactive moiety, Z′, are different.

3. The method of claim 1 , wherein the first reactive moiety, Z, and the second reactive moiety, Z′, are the same.

4. The method of claim 3 , wherein the first reactive moiety, Z, and the second reactive moiety, Z′, are selected from the group consisting of active esters, active carbonates, aldehydes, isocyanates, isothiocyanates, epoxides, alcohols, maleimides, vinylsulfones, hydrazides, dithiopyridines, and iodoacetamides.

5. The method of claim 4 , wherein the water soluble polymer comprises the following structure:

wherein the first reactive moiety, Z, and the second reactive moiety, Z′, are each maleimide, and each of POLY, Y, W and W′ is as previously above.

6. The method of claim 1 , wherein the first tethering group, W, and the second tethering group, W′, are each independently selected from the group of CH 2 , alkyl chains, ether chains, amide chains, and combinations thereof.

7. The method of claim 1 , wherein the hydrolytically stable linkage, Y, is selected from the group consisting of —O—, —S—, —O 2 C—NH—, —OCH 2 CH 2 —, —OCH 2 CH 2 CONH—, and —CO—NH—.

8. The method of claim 6 , wherein Y is —O—C(O)—NH— or —C(O)—NH—.

9. The method of claim 1 , wherein the water-soluble, substantially non-immunogenic polymer, POLY, is a poly(ethylene glycol).

10. The method of claim 9 , wherein the poly(ethylene glycol) comprises a capping group.

11. The method of claim 9 , wherein the poly(ethylene glycol) is a linear poly(ethylene glycol).

12. The method of claim 11 , wherein the linear poly(ethylene glycol) comprises the following structure: —CH 2 CH 2 O—(CH 2 CH 2 O) n —CH 2 CH 2 — wherein (n) is from about 8 to about 4000.

13. The method of claim 12 , wherein the poly(ethylene glycol) has a molecular weight of from about 200 Da to about 100,000 Da.

14. The method of claim 12 , wherein the water soluble polymer comprises the following structure:

wherein (n) is from about 8 to about 4000 and each of W and W′ is as previously defined.

15. The method of claim 14 , wherein the poly(ethylene glycol) has a molecular weight of about 5,000 Da.

16. The method of claim 14 , wherein the poly(ethylene glycol) has a molecular weight of about 20,000 Da.

17. The method of claim 12 , wherein the water soluble polymer comprises the following structure:

wherein (n) is from about 8 to about 4000 and each of W and W′ is as previously defined.

18. The method of claim 17 , wherein the poly(ethylene glycol) has a molecular weight of about 5,000 Da.

19. The method of claim 17 , wherein the poly(ethylene glycol) has a molecular weight of about 20,000 Da.

20. The method of claim 12 , wherein the water soluble polymer comprises the following structure:

wherein (n) is from about 8 to about 4000 and each of W and W′ is as previously defined.

21. The method of claim 12 , wherein the water soluble polymer comprises the following structure:

wherein (n) is from about 8 to about 4000 and each of W and W′ is as previously defined.

22. The method of claim 9 , wherein the poly(ethylene glycol) is a branched poly(ethylene glycol).

23. The method of claim 22 , wherein the branched poly(ethylene glycol) is derived from lysine.

24. The method of claim 23 , wherein the water soluble polymer comprises the following structure:

wherein each (n) is independently from about 8 to about 4000 and each of W and W′ is as previously defined.

25. The method of claim 24 , wherein each poly(ethylene glycol) has a molecular weight of about 5,000 Da.

26. The method of claim 24 , wherein each poly(ethylene glycol) has a molecular weight of about 20,000 Da.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →